Source link : https://newshealth.biz/health-news/new-btk-inhibitor-makes-case-for-earlier-use-in-cll/
(MedPage Today) — ORLANDO — Patients with newly diagnosed chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL) lived significantly longer without disease progression when treated with the Bruton’s tyrosine kinase (BTK) inhibitor… Source link : https://www.medpagetoday.com/meetingcoverage/ashhematology/118905 Author : Publish date : 2025-12-09 15:30:00 Copyright for syndicated content belongs to the linked Source.
The post New BTK Inhibitor Makes Case for Earlier Use in CLL first appeared on News Health.
—-
Author : News Health
Publish date : 2025-12-09 15:30:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8